F.D.A. Allows New Remedy for Arthritis
Saturday, April 25, 2009 - 01:00
in Mathematics & Economics
The new drug is a follow-up to Remicade, which is marketed in the United States by Johnson & Johnson and in Europe and in other countries by the Schering-Plough Corporation.